These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 26582133)

  • 1. Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.
    Vieira NM; Elvers I; Alexander MS; Moreira YB; Eran A; Gomes JP; Marshall JL; Karlsson EK; Verjovski-Almeida S; Lindblad-Toh K; Kunkel LM; Zatz M
    Cell; 2015 Nov; 163(5):1204-1213. PubMed ID: 26582133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Balog-Alvarez C; Cai JJ; Davis BW; Kornegay JN
    BMC Genomics; 2016 Aug; 17(1):665. PubMed ID: 27549615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA.
    Lambert MR; Spinazzola JM; Widrick JJ; Pakula A; Conner JR; Chin JE; Owens JM; Kunkel LM
    Mol Ther; 2021 Mar; 29(3):1086-1101. PubMed ID: 33221436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne muscular dystrophy: Ringo to the rescue?
    Cohn RD; Dubowitz V
    Neuromuscul Disord; 2016 Jan; 26(1):5-6. PubMed ID: 26801251
    [No Abstract]   [Full Text] [Related]  

  • 6. MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.
    Alexander MS; Kawahara G; Motohashi N; Casar JC; Eisenberg I; Myers JA; Gasperini MJ; Estrella EA; Kho AT; Mitsuhashi S; Shapiro F; Kang PB; Kunkel LM
    Cell Death Differ; 2013 Sep; 20(9):1194-208. PubMed ID: 23764775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN
    Skelet Muscle; 2017 May; 7(1):9. PubMed ID: 28526070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation.
    Barthélémy I; Calmels N; Weiss RB; Tiret L; Vulin A; Wein N; Peccate C; Drougard C; Beroud C; Deburgrave N; Thibaud JL; Escriou C; Punzón I; Garcia L; Kaplan JC; Flanigan KM; Leturcq F; Blot S
    Skelet Muscle; 2020 Aug; 10(1):23. PubMed ID: 32767978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A normal life without muscle dystrophin.
    Zatz M; Vieira NM; Zucconi E; Pelatti M; Gomes J; Vainzof M; Martins-Bach AB; Garcia Otaduy MC; Bento dos Santos G; Amaro E; Landini V; Andrade T
    Neuromuscul Disord; 2015 May; 25(5):371-4. PubMed ID: 25770920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milder course in Duchenne patients with nonsense mutations and no muscle dystrophin.
    Zatz M; Pavanello RC; Lazar M; Yamamoto GL; Lourenço NC; Cerqueira A; Nogueira L; Vainzof M
    Neuromuscul Disord; 2014 Nov; 24(11):986-9. PubMed ID: 25047667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy.
    Schatzberg SJ; Anderson LV; Wilton SD; Kornegay JN; Mann CJ; Solomon GG; Sharp NJ
    Muscle Nerve; 1998 Aug; 21(8):991-8. PubMed ID: 9655116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Li J; Nghiem P; Detwiler DA; Larsen CA; Grange RW; Bhavaraju-Sanka RK; Tou S; Keene BP; Howard JF; Wang J; Fan Z; Schatzberg SJ; Styner MA; Flanigan KM; Xiao X; Hoffman EP
    Mamm Genome; 2012 Feb; 23(1-2):85-108. PubMed ID: 22218699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.
    Zucconi E; Valadares MC; Vieira NM; Bueno CR; Secco M; Jazedje T; da Silva HC; Vainzof M; Zatz M
    Neuromuscul Disord; 2010 Jan; 20(1):64-70. PubMed ID: 19944604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
    Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
    Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscular dystrophy in a family of Labrador Retrievers with no muscle dystrophin and a mild phenotype.
    Vieira NM; Guo LT; Estrela E; Kunkel LM; Zatz M; Shelton GD
    Neuromuscul Disord; 2015 May; 25(5):363-70. PubMed ID: 25813339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
    Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G
    Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
    Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M
    Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.
    Martin PT; Golden B; Okerblom J; Camboni M; Chandrasekharan K; Xu R; Varki A; Flanigan KM; Kornegay JN
    PLoS One; 2014; 9(2):e88226. PubMed ID: 24505439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.